Opko Health(OPK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OPK Opko Health

交易中 01-06 15:58:46 EST

1.32

+0.04

+3.13%

最高1.33	最低1.27	成交量230.18万
今开1.27	昨收1.28	日振幅4.30%
总市值10.13亿	流通市值4.63亿	总股本7.68亿
成交额300.70万	换手率0.66%	流通股本3.51亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"OPK","market":"US","secType":"STK","nameCN":"Opko Health","latestPrice":1.32,"timestamp":1767733125542,"preClose":1.28,"halted":0,"volume":2301752,"delay":0,"floatShares":351000000,"shares":767701280,"eps":-0.247502,"marketStatus":"交易中","change":0.04,"latestTime":"01-06 15:58:46 EST","open":1.27,"high":1.325,"low":1.27,"amount":3007041.4976784,"amplitude":0.042969,"askPrice":1.33,"askSize":91241,"bidPrice":1.32,"bidSize":65649,"shortable":3,"etf":0,"ttmEps":-0.247502,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1767733200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.28,"preHourTrading":{"tag":"盘前","latestPrice":1.28,"preClose":1.28,"latestTime":"09:29 EST","volume":4617,"amount":5899.6353807,"timestamp":1767709799907},"postHourTrading":{"tag":"盘后","latestPrice":1.28,"preClose":1.28,"latestTime":"19:52 EST","volume":11616,"amount":14863.961,"timestamp":1767660743668},"volumeRatio":0.418936,"impliedVol":0.546,"impliedVolPercentile":0.22},"requestUrl":"/m/hq/s/OPK","defaultTab":"news","newsList":[{"id":"2580042701","title":"Opko健康盘中异动 下午盘股价大跌5.14%报1.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580042701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580042701?lang=zh_cn&edition=full","pubTime":"2025-11-01 01:07","pubTimestamp":1761930463,"startTime":"0","endTime":"0","summary":"北京时间2025年11月01日01时07分，Opko健康股票出现异动，股价大幅下挫5.14%。截至发稿，该股报1.39美元/股，成交量201.703万股，换手率0.26%，振幅3.77%。Opko健康股票所在的生命科学行业中，整体涨幅为1.47%。公司大部分收入来自诊断部门。消息层面，截至01时07分，《Ladenburg Thalmann维持Opko健康买入评级，下调目标价至3美元》资讯为影响Opko健康的重要信息。根据TipRanks数据显示，该分析师近一年总胜率为38.8%，总平均回报率为20.0%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251101010744a6d946e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251101010744a6d946e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4196","OPK"],"gpt_icon":0},{"id":"1102672282","title":"OPKO Health - Modex 有资格获得分级全球净销售版税，最高可达低双位数","url":"https://stock-news.laohu8.com/highlight/detail?id=1102672282","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102672282?lang=zh_cn&edition=full","pubTime":"2025-10-29 20:05","pubTimestamp":1761739516,"startTime":"0","endTime":"0","summary":"OPKO Health - Modex 有资格获得分级全球净销售版税，最高可达低双位数","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1917777945.USD","LU1974910355.USD","LU0882574055.USD","BK4588","LU2362540622.SGD","BK4585","LU0289739699.SGD","LU0058720904.USD","LU0053666078.USD","LU2023250504.SGD","BK4139","LU0823434583.USD","LU2237438978.USD","LU2089984988.USD","LU0114720955.EUR","LU2468319806.SGD","LU2362541273.HKD","LU2362541513.USD","LU0889565916.HKD","BK4196","LU0823434740.USD","REGN","LU0823416689.USD","OPK","LU0320765992.SGD","LU2106854487.HKD","LU0109394709.USD"],"gpt_icon":0},{"id":"1130077520","title":"异动解读 | OPKO Health与再生元制药达成合作，盘前股价大涨7.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=1130077520","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130077520?lang=zh_cn&edition=full","pubTime":"2025-10-29 20:04","pubTimestamp":1761739482,"startTime":"0","endTime":"0","summary":"周三盘前，OPKO Health股价大涨7.64%，引起投资者广泛关注。这一显著涨幅与公司最新发布的重要合作消息密切相关。据悉，OPKO Health旗下的Modex Therapeutics与知名制药公司再生元制药达成研究合作协议。分析人士指出，与再生元制药这样的行业巨头合作，不仅有助于OPKO Health提升其研发实力和行业地位，还可能为公司带来可观的经济效益。投资者对这一合作表现出强烈的兴趣，推动了OPKO Health股价的大幅上涨。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["OPK"],"gpt_icon":0},{"id":"1179192466","title":"OPKO Health旗下Modex Therapeutics与再生元制药公司达成研究合作，开发针对特定治疗适应症的多特异性抗体","url":"https://stock-news.laohu8.com/highlight/detail?id=1179192466","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179192466?lang=zh_cn&edition=full","pubTime":"2025-10-29 20:02","pubTimestamp":1761739338,"startTime":"0","endTime":"0","summary":"OPKO Health旗下Modex Therapeutics与再生元制药公司达成研究合作，开发针对特定治疗适应症的多特异性抗体。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541513.USD","LU0109394709.USD","BK4196","LU2089984988.USD","BK4588","LU0053666078.USD","BK4139","LU2362540622.SGD","LU2468319806.SGD","LU0889565916.HKD","LU0882574055.USD","LU2023250504.SGD","LU0289739699.SGD","REGN","LU0823434740.USD","LU0058720904.USD","LU0823434583.USD","OPK","LU0114720955.EUR","LU1974910355.USD","LU2362541273.HKD","LU1917777945.USD","LU2106854487.HKD","LU2237438978.USD","LU0823416689.USD","LU0320765992.SGD","BK4585"],"gpt_icon":0},{"id":"1189816664","title":"Opko Health的Modex Therapeutics启动Mdx2004治疗晚期癌症的临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1189816664","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189816664?lang=zh_cn&edition=full","pubTime":"2025-10-28 20:02","pubTimestamp":1761652922,"startTime":"0","endTime":"0","summary":"Opko Health的Modex Therapeutics启动Mdx2004治疗晚期癌症的临床试验","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4139","OPK"],"gpt_icon":0},{"id":"2558666980","title":"Opko健康盘中异动 大幅上涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558666980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558666980?lang=zh_cn&edition=full","pubTime":"2025-08-11 22:19","pubTimestamp":1754921990,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日22时19分，Opko健康股票出现波动，股价大幅上涨5.60%。截至发稿，该股报1.32美元/股，成交量123.181万股，换手率0.16%，振幅3.20%。Opko健康股票所在的生命科学行业中，整体涨幅为0.23%。其相关个股中，Radnet, Inc.、Genedx Holdings Corp C/Wts 22/07/2026 、Opko健康涨幅较大，Ispecimen Inc.、Applied Dna Sciences, Inc.、Endra Life Sciences Inc.较为活跃，换手率分别为3.85%、1.88%、1.84%，振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Radnet, Inc.、Biodesix, Inc.，振幅分别为24.55%、13.02%、9.61%。公司大部分收入来自诊断部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811221950a4822a6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811221950a4822a6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPK","BK4139","BK4196"],"gpt_icon":0},{"id":"2558350242","title":"Opko健康2025财年第二财季实现净利润-1.48亿美元，同比减少1335.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558350242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558350242?lang=zh_cn&edition=full","pubTime":"2025-08-10 00:00","pubTimestamp":1754755237,"startTime":"0","endTime":"0","summary":"8月10日，Opko健康公布财报，公告显示公司2025财年第二财季净利润为-1.48亿美元，同比减少1335.50%；其中营业收入为1.57亿美元，同比减少13.74%，每股基本收益为-0.19美元。从资产负债表来看，Opko健康总负债6.76亿美元，其中短期债务25.51百万美元，资产负债比为2.92，流动比率为3.41。机构评级：截至2025年8月10日，当前有6家机构对Opko健康目标价做出预测，其中目标均价为3.62美元，其中最低目标价为2.00美元，最高目标价为8.50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810000110a47efb25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810000110a47efb25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPK"],"gpt_icon":1},{"id":"2557520954","title":"Opko健康盘中异动 早盘快速拉升5.69%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557520954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557520954?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:34","pubTimestamp":1754660045,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日21时34分，Opko健康股票出现波动，股价快速上涨5.69%。截至发稿，该股报1.30美元/股，成交量89.741万股，换手率0.11%，振幅1.63%。Opko健康股票所在的生命科学行业中，整体涨幅为0.31%。Opko健康公司简介：OPKO Health Inc是一家多元化的生物技术公司，从事制药和诊断开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808213405a6db2163&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808213405a6db2163&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPK","BK4196","BK4139"],"gpt_icon":0},{"id":"2557701333","title":"Opko健康盘中异动 下午盘快速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557701333","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557701333?lang=zh_cn&edition=full","pubTime":"2025-08-05 01:08","pubTimestamp":1754327334,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日01时08分，Opko健康股票出现波动，股价快速拉升5.04%。截至发稿，该股报1.25美元/股，成交量166.033万股，换手率0.21%，振幅6.30%。机构评级方面，在所有6家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Opko健康股票所在的生命科学行业中，整体涨幅为3.59%。Opko健康公司简介：OPKO Health Inc是一家多元化的生物技术公司，从事制药和诊断开发项目。公司大部分收入来自诊断部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805010854973353ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805010854973353ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPK","BK4196","BK4139"],"gpt_icon":0},{"id":"1176543448","title":"异动解读 | Opko Health股价盘中大跌7.04%，分析师预期季度业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=1176543448","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176543448?lang=zh_cn&edition=full","pubTime":"2025-08-01 21:50","pubTimestamp":1754056240,"startTime":"0","endTime":"0","summary":"8月1日周五，生物医药公司Opko Health股价在盘中大跌7.04%，引发市场广泛关注。根据LSEG的数据，分析师平均预期Opko Health在截至2025年9月30日的季度中每股将亏损7美分。值得注意的是，Opko Health在过去两个季度的财报表现不佳，均未能达到分析师的预期。这种分歧凸显了Opko Health当前面临的挑战与未来潜力之间的矛盾，投资者在做出决策时需要谨慎权衡多方面因素。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["OPK"],"gpt_icon":0},{"id":"1169954649","title":"异动解读 | Opko Health股价盘中大跌7%，市场担忧即将公布的季度财报","url":"https://stock-news.laohu8.com/highlight/detail?id=1169954649","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169954649?lang=zh_cn&edition=full","pubTime":"2025-08-01 21:50","pubTimestamp":1754056238,"startTime":"0","endTime":"0","summary":"周五盘中，生物医药公司Opko Health股价大跌7.04%，投资者对即将公布的季度财报表现出强烈担忧。根据LSEG的数据，分析师平均预期Opko Health在截至2025年9月30日的季度中每股将亏损7美分。值得注意的是，Opko Health在过去几个季度的财报表现不佳。尽管如此，分析师仍对该公司保持乐观态度，目前对Opko Health的平均评级为\"强力买入\"，12个月目标价中位数为3.00美元，较最近收盘价1.28美元高出约57.5%。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["OPK"],"gpt_icon":0},{"id":"1118985755","title":"异动解读 | Opko Health盘前大跌6.25%，分析师预期每股亏损7美分","url":"https://stock-news.laohu8.com/highlight/detail?id=1118985755","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118985755?lang=zh_cn&edition=full","pubTime":"2025-08-01 20:19","pubTimestamp":1754050761,"startTime":"0","endTime":"0","summary":"周五盘前，生物医药公司Opko Health股价大跌6.25%，投资者对即将公布的季度财报表现出担忧。根据LSEG的数据，分析师平均预期Opko Health在截至2025年9月30日的季度中每股将亏损7美分。值得注意的是，Opko Health在过去几个季度的财报表现不佳。尽管如此，分析师仍对该公司保持乐观态度，目前对Opko Health的平均评级为\"强力买入\"，12个月目标价中位数为3.00美元，较最近收盘价1.28美元高出约57.5%。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["OPK"],"gpt_icon":0},{"id":"1173605491","title":"异动解读 | Opko Health盘前大跌6.25%，分析师预期公司业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=1173605491","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173605491?lang=zh_cn&edition=full","pubTime":"2025-08-01 20:19","pubTimestamp":1754050752,"startTime":"0","endTime":"0","summary":"周五盘前，生物制药公司Opko Health股价大跌6.25%，投资者对公司即将公布的季度财报感到担忧。根据LSEG的数据，分析师平均预期Opko Health在截至2025年9月30日的季度中每股将亏损7美分。此外，6位分析师的平均预期显示，公司营收将同比下降3.7%至1.6722亿美元，低于去年同期的1.736亿美元。值得注意的是，Opko Health在过去几个季度的表现并不稳定。公司在2025年6月30日和3月31日结束的两个季度中都未能达到分析师的预期，分别出现67.7%和45.8%的负面意外。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["OPK"],"gpt_icon":0},{"id":"2556853970","title":"Opko健康盘中异动 临近收盘急速下跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556853970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556853970?lang=zh_cn&edition=full","pubTime":"2025-08-01 03:48","pubTimestamp":1753991302,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日03时48分，Opko健康股票出现异动，股价大幅下挫5.22%。截至发稿，该股报1.27美元/股，成交量293.852万股，换手率0.37%，振幅4.48%。Opko健康股票所在的生命科学行业中，整体跌幅为2.54%。Opko健康公司简介：OPKO Health Inc是一家多元化的生物技术公司，从事制药和诊断开发项目。诊断部门由通过BioReference开展的临床和基因组学实验室业务以及现场护理业务构成。公司大部分收入来自诊断部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801034823a46e1bf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801034823a46e1bf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPK","BK4196","BK4139"],"gpt_icon":0},{"id":"2518447759","title":"Opko健康2024财年实现净利润-53.22百万美元，同比增加71.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518447759","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518447759?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:00","pubTimestamp":1741449628,"startTime":"0","endTime":"0","summary":"3月9日，Opko健康公布财报，公告显示公司2024财年净利润为-53.22百万美元，同比增加71.84%；其中营业收入为7.13亿美元，同比减少17.38%，每股基本收益为-0.08美元。从资产负债表来看，Opko健康总负债8.35亿美元，其中短期债务29.35百万美元，资产负债比为2.64，流动比率为3.44。机构评级：截至2025年3月9日，当前有6家机构对Opko健康目标价做出预测，其中目标均价为3.99美元，其中最低目标价为2.00美元，最高目标价为8.50美元。Opko的诊断业务包括一个核心的基因检测业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000104abef9722&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000104abef9722&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPK"],"gpt_icon":0},{"id":"2517087605","title":"Opko健康盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517087605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517087605?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:55","pubTimestamp":1741103714,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时55分，Opko健康股票出现波动，股价大幅上涨5.14%。截至发稿，该股报1.84美元/股，成交量333.718万股，换手率0.50%，振幅4.57%。机构评级方面，在所有6家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Opko健康股票所在的生命科学行业中，整体跌幅为1.40%。Opko健康公司简介：OPKO Health Inc是一家多元化的生物技术公司，经营制药和诊断开发项目。Opko的诊断业务包括一个核心的基因检测业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304235514abe80681&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304235514abe80681&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDSX","OPK","BK4196","BK4139"],"gpt_icon":1},{"id":"2514337615","title":"Barrington Research：维持OPKO Health(OPK.US)评级，由优于大市调整至优于大市评级, 目标价由2.25美元调整至2.25美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514337615","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514337615?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:41","pubTimestamp":1740757319,"startTime":"0","endTime":"0","summary":"Barrington Research：维持OPKO Health(OPK.US)评级，由优于大市调整至优于大市评级, 目标价由2.25美元调整至2.25美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28234148468150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["OPK"],"gpt_icon":0},{"id":"2514637390","title":"Opko健康盘中异动 早盘股价大涨5.53%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514637390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514637390?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:33","pubTimestamp":1740753210,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时33分，Opko健康股票出现波动，股价急速拉升5.53%。截至发稿，该股报1.72美元/股，成交量30.0261万股，换手率0.04%，振幅2.45%。Opko健康股票所在的生命科学行业中，整体涨幅为0.59%。Opko健康公司简介：OPKO Health Inc是一家多元化的生物技术公司，经营制药和诊断开发项目。Opko的诊断业务包括一个核心的基因检测业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223330963419b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223330963419b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","BK4139","OPK"],"gpt_icon":0},{"id":"1120418812","title":"OPKO Health公司第四季度每股收益0.02美元，超出预期的（0.09）美元，销售额183.60百万美元，超预期的155.42百万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120418812","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120418812?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:31","pubTimestamp":1740691895,"startTime":"0","endTime":"0","summary":"OPKO Health报告季度每股收益0.02美元，超出分析师预期的美元，增长了122.22%。公司报告季度销售额为183.60百万美元，超出分析师预期的155.42百万美元，增长了18.13%。与去年同期的181.90百万美元销售额相比增长了0.93%。以上内容来自Benzinga Earnings专栏，原文如下：OPKO Health  reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $ by 122.22 percent. This is a 122.22 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $183.60 million which beat the analyst consensus estimate of $155.42 million by 1","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"OPKO Health公司第四季度每股收益0.02美元，超出预期的（0.09）美元，销售额183.60百万美元，超预期的155.42百万美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPK"],"gpt_icon":0},{"id":"2514001782","title":"Opko健康盘中异动 大幅下跌5.20%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514001782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514001782?lang=zh_cn&edition=full","pubTime":"2025-02-26 01:24","pubTimestamp":1740504251,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日01时24分，Opko健康股票出现波动，股价急速下跌5.20%。截至发稿，该股报1.63美元/股，成交量100.688万股，换手率0.15%，振幅5.52%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Opko健康股票所在的生命科学行业中，整体涨幅为0.16%。Opko健康公司简介：OPKO Health Inc是一家多元化的生物技术公司，经营制药和诊断开发项目。Opko的诊断业务包括一个核心的基因检测业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022601241198926fdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022601241198926fdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","OPK","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.opko.com","stockEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":-0.0448},{"period":"3month","weight":-0.1688},{"period":"6month","weight":-0.0725},{"period":"1year","weight":-0.1351},{"period":"ytd","weight":0.0159}],"compareEarnings":[{"period":"1week","weight":-0.0002},{"period":"1month","weight":0.003},{"period":"3month","weight":0.0278},{"period":"6month","weight":0.102},{"period":"1year","weight":0.1618},{"period":"ytd","weight":0.0085}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"OPKO Health, Inc.最初于1991年10月在特拉华州注册成立。该公司是一家多元化的医疗保健公司，寻求在大型且快速增长的医疗市场中建立行业领先地位。该公司的制药业务包括美国食品药品监督管理局（Food and Drug Administration）批准的用于治疗患有3或4期慢性肾病和维生素D不足的成人继发性甲状旁腺功能亢进的Rayaldee，以及每周一次的人生长激素注射液Somatrogon，该公司已与辉瑞公司就Somatrogon的进一步开发和商业化进行合作。","yearOnYearQuotes":[{"month":1,"riseRate":0.526316,"avgChangeRate":0.001477},{"month":2,"riseRate":0.444444,"avgChangeRate":0.001375},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.008865},{"month":4,"riseRate":0.444444,"avgChangeRate":0.001842},{"month":5,"riseRate":0.444444,"avgChangeRate":0.026217},{"month":6,"riseRate":0.555556,"avgChangeRate":0.090883},{"month":7,"riseRate":0.578947,"avgChangeRate":0.067954},{"month":8,"riseRate":0.473684,"avgChangeRate":-0.019434},{"month":9,"riseRate":0.368421,"avgChangeRate":-0.035146},{"month":10,"riseRate":0.473684,"avgChangeRate":-0.00998},{"month":11,"riseRate":0.684211,"avgChangeRate":0.014234},{"month":12,"riseRate":0.368421,"avgChangeRate":-0.021498}],"exchange":"NASDAQ","name":"Opko Health","nameEN":"OPKO Health"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Opko Health(OPK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Opko Health(OPK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Opko Health,OPK,Opko Health股票,Opko Health股票老虎,Opko Health股票老虎国际,Opko Health行情,Opko Health股票行情,Opko Health股价,Opko Health股市,Opko Health股票价格,Opko Health股票交易,Opko Health股票购买,Opko Health股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Opko Health(OPK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Opko Health(OPK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}